Africa: Health Advocates Urge Africa to Adopt Who Glp-1 Obesity Guidelines
Nairobi — Health advocates are calling on African governments to leverage new World Health Organisation (WHO) guidelines on the use of Glucagon-Like Peptide-1 (GLP-1) therapies to prevent and treat obesity, warning that failure to act could deepen the continent’s growing non-communicable disease burden. In a statement, senior researcher and Stowelink Foundation founder Stephen Ogweno said…
